Yahoo
NYSE - Nasdaq Real Time Price USD

Solventum Corporation (SOLV)

91.30 +4.12 (+4.73%)
As of 11:40:05 AM EST. Market Open.
Trade SOLV on Coinbase
SOLV Q3 2026 earnings call
Replay the call for the latest insights.
Read transcript
Chart Range Bar
Loading chart for SOLV

What's happening with SOLV?

6m ago
Powered by Yahoo Scout

Solventum delivered a mixed third quarter, with an adjusted earnings beat despite lower reported revenue and a net loss. Management raised full-year adjusted earnings guidance while completing major enterprise resource planning transitions and advancing its separation from 3M.

Powered by Yahoo Scout
  • Previous Close 87.18
  • Open 86.45
  • Bid 91.13 x 20000
  • Ask 91.41 x 20000
  • Day's Range 85.04 - 93.00
  • 52 Week Range 62.38 - 94.16
  • Volume 1,063,798
  • Avg. Volume 1,032,228
  • Market Cap (intraday) 15.541B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 102.58
  • EPS (TTM) 0.89
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 94.69
  • Morningstar Rating Rating available with Stock Picks access

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

www.solventum.com

20,584

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SOLV
15.22%
S&P 500 (^GSPC)
8.54%

1-Year Return

SOLV
37.75%
S&P 500 (^GSPC)
10.56%

3-Year Return

SOLV
0.27%
S&P 500 (^GSPC)
70.18%

5-Year Return

SOLV
0.27%
S&P 500 (^GSPC)
58.17%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.95B
Earnings -12M
Profit Margin -0.62%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
2B
2B
0.0%
1.0%
2.0%
3.0%
4.0%

Analyst Insights

View More

Analyst Price Targets

71.00 Low
94.69 Average
91.30 Current
113.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/6/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Equal-Weight
Price Action Raises
Price Target 89 -> 95

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.91%

  • Return on Assets (ttm)

    2.08%

  • Return on Equity (ttm)

    3.19%

  • Revenue (ttm)

    8.16B

  • Net Income Avi to Common (ttm)

    156M

  • Diluted EPS (ttm)

    0.89

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    451M

  • Total Debt/Equity (mrq)

    109.76%

  • Levered Free Cash Flow (ttm)

    165.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: